IFP Advisors, Inc - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$52,000
+62.5%
5,650
+197.4%
0.00%
+200.0%
Q3 2018$32,000
+3.2%
1,900
+5.6%
0.00%0.0%
Q2 2018$31,000
+3000.0%
1,800
+1100.0%
0.00%
Q1 2018$1,0000.0%1500.0%0.00%
Q4 2017$1,000
-50.0%
1500.0%0.00%
Q3 2017$2,000
+100.0%
1500.0%0.00%
Q2 2017$1,000
-50.0%
1500.0%0.00%
Q1 2017$2,000
+100.0%
1500.0%0.00%
Q4 2016$1,0000.0%1500.0%0.00%
Q3 2016$1,000
-75.0%
150
-76.9%
0.00%
Q2 2016$4,000
-42.9%
650
+30.0%
0.00%
Q4 2015$7,0005000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,200,396$30,084,0001.72%
TFS CAPITAL LLC 105,040$987,0000.26%
Tekla Capital Management LLC 500,324$4,703,0000.20%
Piermont Capital Management Inc. 51,080$480,0000.11%
ESSEX INVESTMENT MANAGEMENT CO LLC 55,793$524,0000.09%
Candriam S.C.A. 390,000$3,666,0000.08%
Virtus ETF Advisers LLC 27,446$258,0000.08%
SECOR Capital Advisors, LP 66,484$625,0000.08%
Trexquant Investment LP 29,007$273,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 32,196$303,0000.04%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders